A critical advance in cancer study is occurring with the use of VHH fragments to re-engage damaged p53. This essential cancer inhibitor protein is frequently disabled in various kinds of tumors, resulting uncontrolled https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research